Botfet / Company detail

DXCM

universe

Dexcom

biotech

Moat score60out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic16.6%

Gross Margin60.1%

Revenue Cagr17.5%

Fcf Conversion128.8%

Fcf Yield3.6%

Interest Coverage74.2x

Market Cap B$29.5B

Pe30.1

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant60

Why it may endure

Moat breakdown

Quant: 60 · Curator: 0

Market Share Stability12

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction0/10

Leadership0/10

Vision0/10

← Back to the full screener